(RZLV) Rezolve AI Ordinary Shares - Ratings and Ratios
Exchange: NASDAQ •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: GB00BQH8G337
Ai Platform, Retail, E-Commerce, Consumer, Dynamic
| Risk via 10d forecast | |
|---|---|
| Volatility | 94.7% |
| Value at Risk 5%th | 129% |
| Relative Tail Risk | -17.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | -54.04 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.576 |
| Beta | 1.926 |
| Beta Downside | 1.380 |
| Drawdowns 3y | |
|---|---|
| Max DD | 91.85% |
| Mean DD | 32.12% |
| Median DD | 4.80% |
Description: RZLV Rezolve AI Ordinary Shares November 14, 2025
Rezolve AI PLC (NASDAQ:RZLV) develops generative-AI tools tailored for retailers, brands, and manufacturers, enabling real-time, personalized consumer engagement across multiple channels and devices. The London-based firm, founded in 2016 and rebranded from Rezolve AI Limited to PLC in March 2025, is classified under the GICS Sub-Industry “Application Software.”
Key industry metrics that shape Rezolve’s growth outlook include: (1) global generative-AI market revenue projected to exceed $50 billion by 2027, with a CAGR of ~38 % (IDC, 2024); (2) e-commerce GMV in Europe rising 12 % YoY in Q2 2025, driven by omnichannel adoption; and (3) SaaS-based AI platforms reporting average ARR retention rates above 95 %, indicating strong customer stickiness. Assuming Rezolve can capture even 0.5 % of the European retail AI spend, incremental revenue could reach $15-$20 million annually, subject to execution risk and competitive pressure from larger cloud providers.
For a deeper, data-driven assessment of Rezolve’s valuation and risk profile, you may find ValueRay’s analytical framework a useful next step.
RZLV Stock Overview
| Market Cap in USD | 1,236m |
| Sub-Industry | Application Software |
| IPO / Inception | 2024-08-16 |
| Return 12m vs S&P 500 | -25.4% |
| Analyst Rating | 4.40 of 5 |
RZLV Dividends
Currently no dividends paidRZLV Growth Ratios
| CAGR 3y | -33.62% |
| CAGR/Max DD Calmar Ratio | -0.37 |
| CAGR/Mean DD Pain Ratio | -1.05 |
| Current Volume | 13483.7k |
| Average Volume | 11651.8k |
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-195.6m TTM) > 0 and > 6% of Revenue (6% = 762.1k TTM) |
| FCFTA -0.48 (>2.0%) and ΔFCFTA -1.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -559.5% (prev -26.4k%; Δ 25.8kpp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.48 (>3.0%) and CFO -38.1m > Net Income -195.6m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.24 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (233.5m) change vs 12m ago 12.13% (target <= -2.0% for YES) |
| Gross Margin 95.58% (prev 79.70%; Δ 15.88pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 25.43% (prev 0.86%; Δ 24.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -21.93 (EBITDA TTM -125.9m / Interest Expense TTM 5.88m) >= 6 (WARN >= 3) |
Altman Z'' -39.56
| (A) -0.89 = (Total Current Assets 22.6m - Total Current Liabilities 93.6m) / Total Assets 80.1m |
| (B) -3.95 = Retained Earnings (Balance) -316.1m / Total Assets 80.1m |
| warn (B) unusual magnitude: -3.95 — check mapping/units |
| (C) -2.58 = EBIT TTM -129.0m / Avg Total Assets 49.9m |
| (D) -3.35 = Book Value of Equity -316.4m / Total Liabilities 94.4m |
| Total Rating: -39.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 46.37
| 1. Piotroski 1.0pt = -4.0 |
| 2. FCF Yield -3.03% = -1.51 |
| 3. FCF Margin data missing |
| 4. Debt/Equity -2.49 = -2.50 |
| 5. Debt/Ebitda -0.20 = -2.50 |
| 7. RoE 967.6% = 2.50 |
| 8. Rev. Trend 83.33% = 6.25 |
| 9. EPS Trend -37.24% = -1.86 |
What is the price of RZLV shares?
As of November 17, 2025, the stock is trading at USD 2.95 with a total of 13,483,692 shares traded.
Over the past week, the price has changed by -22.98%, over one month by -45.87%, over three months by -3.91% and over the past year by -14.49%.
Over the past week, the price has changed by -22.98%, over one month by -45.87%, over three months by -3.91% and over the past year by -14.49%.
Is Rezolve AI Ordinary Shares a good stock to buy?
No, based on ValueRay´s Fundamental Analyses, Rezolve AI Ordinary Shares (NASDAQ:RZLV) is currently (November 2025)
a stock to sell. It has a ValueRay Fundamental Rating of 46.37 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RZLV is around 2.32 USD . This means that RZLV is currently overvalued and has a potential downside of -21.36%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RZLV is around 2.32 USD . This means that RZLV is currently overvalued and has a potential downside of -21.36%.
Is RZLV a buy, sell or hold?
Rezolve AI Ordinary Shares has received a consensus analysts rating of 4.40.
Therefore, it is recommended to buy RZLV.
- Strong Buy: 2
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RZLV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10 | 239% |
| Analysts Target Price | 10 | 239% |
| ValueRay Target Price | 2.7 | -8.8% |
RZLV Fundamental Data Overview November 11, 2025
Market Cap USD = 1.24b (1.24b USD * 1.0 USD.USD)
P/S = 233.1219
Beta = -0.233
Revenue TTM = 12.7m USD
EBIT TTM = -129.0m USD
EBITDA TTM = -125.9m USD
Long Term Debt = 121.1k USD (from longTermDebt, two quarters ago)
Short Term Debt = 34.8m USD (from shortTermDebt, last quarter)
Debt = 35.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.26b USD (1.24b + Debt 35.6m - CCE 9.86m)
Interest Coverage Ratio = -21.93 (Ebit TTM -129.0m / Interest Expense TTM 5.88m)
FCF Yield = -3.03% (FCF TTM -38.2m / Enterprise Value 1.26b)
FCF Margin = -300.9% (FCF TTM -38.2m / Revenue TTM 12.7m)
Net Margin = -1540 % (Net Income TTM -195.6m / Revenue TTM 12.7m)
Gross Margin = 95.58% ((Revenue TTM 12.7m - Cost of Revenue TTM 561.0k) / Revenue TTM)
Gross Margin QoQ = 95.63% (prev 95.63%)
Tobins Q-Ratio = 15.75 (Enterprise Value 1.26b / Total Assets 80.1m)
Interest Expense / Debt = 5.93% (Interest Expense 2.11m / Debt 35.6m)
Taxrate = -0.86% (negative due to tax credits) (247.1k / -28.7m)
NOPAT = -130.1m (EBIT -129.0m * (1 - -0.86%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 0.24 (Total Current Assets 22.6m / Total Current Liabilities 93.6m)
Debt / Equity = -2.49 (negative equity) (Debt 35.6m / totalStockholderEquity, last quarter -14.3m)
Debt / EBITDA = -0.20 (negative EBITDA) (Net Debt 25.7m / EBITDA -125.9m)
Debt / FCF = -0.67 (negative FCF - burning cash) (Net Debt 25.7m / FCF TTM -38.2m)
Total Stockholder Equity = -20.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -244.2% (out of range, set to none)
RoE = 967.6% (negative equity) (Net Income TTM -195.6m / Total Stockholder Equity -20.2m)
RoCE = 642.1% (negative capital employed) (EBIT -129.0m / Capital Employed (Equity -20.2m + L.T.Debt 121.1k))
RoIC = -1634 % (out of range, set to none) (NOPAT -130.1m / Invested Capital 7.97m)
WACC = 12.91% (E(1.24b)/V(1.27b) * Re(13.11%) + D(35.6m)/V(1.27b) * Rd(5.93%) * (1-Tc(-0.01)))
Discount Rate = 13.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 437.8%
Fair Price DCF = unknown (Cash Flow -38.2m)
EPS Correlation: -37.24 | EPS CAGR: -71.83% | SUE: N/A | # QB: 0
Revenue Correlation: 83.33 | Revenue CAGR: 979.3% | SUE: N/A | # QB: 0
P/S = 233.1219
Beta = -0.233
Revenue TTM = 12.7m USD
EBIT TTM = -129.0m USD
EBITDA TTM = -125.9m USD
Long Term Debt = 121.1k USD (from longTermDebt, two quarters ago)
Short Term Debt = 34.8m USD (from shortTermDebt, last quarter)
Debt = 35.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.26b USD (1.24b + Debt 35.6m - CCE 9.86m)
Interest Coverage Ratio = -21.93 (Ebit TTM -129.0m / Interest Expense TTM 5.88m)
FCF Yield = -3.03% (FCF TTM -38.2m / Enterprise Value 1.26b)
FCF Margin = -300.9% (FCF TTM -38.2m / Revenue TTM 12.7m)
Net Margin = -1540 % (Net Income TTM -195.6m / Revenue TTM 12.7m)
Gross Margin = 95.58% ((Revenue TTM 12.7m - Cost of Revenue TTM 561.0k) / Revenue TTM)
Gross Margin QoQ = 95.63% (prev 95.63%)
Tobins Q-Ratio = 15.75 (Enterprise Value 1.26b / Total Assets 80.1m)
Interest Expense / Debt = 5.93% (Interest Expense 2.11m / Debt 35.6m)
Taxrate = -0.86% (negative due to tax credits) (247.1k / -28.7m)
NOPAT = -130.1m (EBIT -129.0m * (1 - -0.86%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 0.24 (Total Current Assets 22.6m / Total Current Liabilities 93.6m)
Debt / Equity = -2.49 (negative equity) (Debt 35.6m / totalStockholderEquity, last quarter -14.3m)
Debt / EBITDA = -0.20 (negative EBITDA) (Net Debt 25.7m / EBITDA -125.9m)
Debt / FCF = -0.67 (negative FCF - burning cash) (Net Debt 25.7m / FCF TTM -38.2m)
Total Stockholder Equity = -20.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -244.2% (out of range, set to none)
RoE = 967.6% (negative equity) (Net Income TTM -195.6m / Total Stockholder Equity -20.2m)
RoCE = 642.1% (negative capital employed) (EBIT -129.0m / Capital Employed (Equity -20.2m + L.T.Debt 121.1k))
RoIC = -1634 % (out of range, set to none) (NOPAT -130.1m / Invested Capital 7.97m)
WACC = 12.91% (E(1.24b)/V(1.27b) * Re(13.11%) + D(35.6m)/V(1.27b) * Rd(5.93%) * (1-Tc(-0.01)))
Discount Rate = 13.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 437.8%
Fair Price DCF = unknown (Cash Flow -38.2m)
EPS Correlation: -37.24 | EPS CAGR: -71.83% | SUE: N/A | # QB: 0
Revenue Correlation: 83.33 | Revenue CAGR: 979.3% | SUE: N/A | # QB: 0
Additional Sources for RZLV Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle